World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Keywords:
Tags:
Abbott Laboratories agreement to pay $1.6 billion in civil and criminal fines for promoting unapproved off label uses of the neurologic drug Depakote, to sedate older patients in nursing homes. The acting associate attorney general, Tony West, said: "Not only did Abbott engage in off-label promotion, it targeted elderly dementia patients and down played the risks apparent from its own clinical studies." Abbott aggressively promoted its use in nursing homes. It also aggressively promoted the use of the drug for schizophrenia between 2001 and 2006. In 1999 Abbott had to discontinue a clinical trial testing Depakote's effectiveness against dementia after results showed increased incidence of anorexia, drowsiness and dehydration.
Abbott Labs's $1.6 billion legal settlement for aggressive marketing of neurologic drug Depakote in U.S. nursing homes
04/10/2007
Grouped Articles
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Abbott to Pay $1.6 Billion Over Illegal Marketing
New York Times 05/07/2012
Wall Street Journal 05/08/2012
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07/20/2012
FDA Cancer Czar Stirs Debate On Agency's Role
Wall Street Journal 03/12/2008
Stronger Warnings on 3 Drugs for Anemia
New York Times 11/09/2007
Abbott marketing
12/06/2010
Grouped Articles
Wall Street Journal 12/06/2010
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Abbott to Pay $1.6 Billion Over Illegal Marketing
New York Times 05/07/2012
Abbott drug approvals
05/27/2011
Grouped Articles
Abbott Dealt Blow in Cholesterol Drug Trial
Wall Street Journal 05/27/2011
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Abbott to Pay $1.6 Billion Over Illegal Marketing
New York Times 05/07/2012
Abbott Is Challenging Biotech Drug Copies
Wall Street Journal 06/21/2012
Abbott restructuring.
08/22/2008
Grouped Articles
Abbott Will Cut 1,000 Jobs in Efficiency Bid
Wall Street Journal 08/22/2008
Abbott Labs to Split into 2 Companies
New York Times 10/20/2011
Abbott to Split Into Two Companies
Wall Street Journal 10/20/2011
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Abbott to Pay $1.6 Billion Over Illegal Marketing
New York Times 05/07/2012
Changes underway in the pharmaceutical industry.
12/06/2007
Old ways are disappearing, and the pharmaceutical industry will look very different ten years from now from what it is today.
Grouped Articles
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12/16/2013
Big Pharma Faces Grim Prognosis
Wall Street Journal 12/06/2007
New York Times 06/25/2009
New Conflict Rules at Medical Journals
Wall Street Journal 10/14/2009
Using a Pfizer Grant, Courses Aim to Avoid Bias
New York Times 01/11/2010
Drug Firms Feel Pinch From Europe
Wall Street Journal 07/29/2010
Large legal settlements in the pharmaceutical industry.
10/25/2006
The settlements also involve drug pricing and marketing.
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
In Guilty Plea, OxyContin Maker to Pay $600 Million
New York Times 05/10/2007
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07/10/2008
Drug Approval Is Not a Shield From Lawsuits, Justices Rule
New York Times 03/05/2009
Abbott Labs product quality and safety.
09/23/2010
Grouped Articles
Beetles Prompt Recall of Similac Baby Formula
Wall Street Journal 09/23/2010
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Abbott to Pay $1.6 Billion Over Illegal Marketing
New York Times 05/07/2012
Wall Street Journal 05/08/2012
Abbott Labs performance
10/19/2006
Grouped Articles
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott to Split Into Two Companies
Wall Street Journal 10/20/2011
Abbott Labs Licenses Molecules from Reata
Wall Street Journal 12/12/2011
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott Is Buoyed By Arthritis Drug, Guidant's Stents - WSJ.com
Wall Street Journal 10/19/2006
Abbott legal settlements
05/07/2012
Grouped Articles
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Abbott to Pay $1.6 Billion Over Illegal Marketing
New York Times 05/07/2012
Changing roles in pharmaceutical sales in the U.S. and Europe- 2011-2014
01/10/2012
Grouped Articles
Drug Reps Soften Their Sales Pitches
Wall Street Journal 01/10/2012
U.S. to Tell Drug Makers to Disclose Payments to Doctors
New York Times 01/16/2012
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07/20/2012
FDA and the drug safety, production and marketing practices of pharmaceutical companies.
07/01/2005
The increasing controversy surrounding the safety and marketing of many pharmaceutical products and the role of the FDA in ensuring safe use and avoiding risks to users.
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
FDA Plan Would Aid Drug Makers in Liability Suits
Wall Street Journal 01/14/2006
FDA Moves Toward Harder Line on Suicide Risks
Wall Street Journal 07/01/2005
Baxter Infusion Pumps Are Target of FDA Probe
Wall Street Journal 07/22/2005
Financial Ties to Industry Cloud Major Depression Study
Wall Street Journal 07/11/2006
Avandia Concerns Reopen a Wider Debate
Wall Street Journal 05/23/2007
Abbott Labs and aggressive marketing from stent use in hospitals to use of Depakote in nursing homes
12/06/2010
Linked Articles
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Wall Street Journal 12/06/2010
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us